Medicare lets device makers set their own reimbursement rates for pediatric tech

What it does

This bill directs Medicare to establish payment rates (called 'relative value units') for pediatric medical devices and technologies that lack them, upon manufacturer request. Manufacturers can submit requests by May 1 each year to have their pediatric device added to Medicare's payment schedule for implementation the same year; requests after May 1 are processed the following year. The bill does not require Medicare to cover any device—only to set a payment rate if the device is already covered, FDA-approved, and used primarily on children.

Why we flagged it

The bill's core function is to create an expedited, manufacturer-initiated process for establishing Medicare payment rates for pediatric medical devices. While framed as access facilitation, the operative mechanism is a reimbursement-rate-setting procedure that gives manufacturers significant control over timing and data submission.

What the text implies

• Manufacturers can strategically time requests (by May 1) to accelerate payment-rate establishment, creating a competitive advantage for well-resourced companies with sophisticated regulatory affairs teams.
• The bill permits manufacturers to submit their own pricing data, claims data, and 'other information' to support payment-rate requests, with no requirement for independent verification or competing data sources—creating asymmetric information advantage.
• Once a payment rate is established via this pathway, it becomes part of the permanent physician fee schedule, locking in the manufacturer-supplied valuation unless Medicare later undertakes a separate rulemaking to revise it.
• The bill does not define 'predominantly performed on pediatric patients' or establish a threshold, leaving ambiguity about which devices qualify and potentially allowing adult-use devices to be classified as pediatric.
• By routing requests through the annual rulemaking process, the bill may accelerate payment-rate adoption compared to traditional coverage review, potentially bypassing more rigorous health-economic analysis.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill may improve access to pediatric medical devices by streamlining the process for establishing Medicare payment rates, potentially benefiting children and families who depend on these technologies. However, the mechanism—allowing manufacturers to trigger automatic rulemaking and providing them a direct pathway to set payment rates using their own data—creates a capture risk: manufacturers control the timing, data submission, and framing of their own reimbursement requests, potentially inf

Who stands to gain

• pediatric medical device manufacturers
• medical device companies with FDA-approved pediatric technologies

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Secretary of Health and Human Services, FDA (Food and Drug Administration), pediatric medical device manufacturers, Medicare, physician fee schedule

Where it stands

16 cosponsors: 10 Democrats, 6 Republicans.

• Mar 6, 2025 — Introduced · Congress.gov: “Introduced in House”
• Mar 6, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.